The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis

Autor: Ewa Wielosz, Magdalena Dryglewska, Maria Majdan

Publikováno v: Annals of Agricultural and Environmental Medicine, Vol 28, Iss 1, Pp 189-192 (2021)

Introduction Anti-PM/Scl (a-PM/Scl) antibodies are found in different systemic autoimmune diseases such as polymyositis, dermatomyositis, systemic sclerosis (SSc) and overlap syndromes. According to literature, they are detected in approx. 2% of SSc

Externí odkaz: https://doaj.org/article/d802a40f0268473586b8bbaf8e36d967

Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis.

Autor: Bogdan Kolarz, Marek Ciesla, Magdalena Dryglewska, Ann K Rosenthal, Maria Majdan

Publikováno v: PLoS ONE, Vol 15, Iss 6, p e0233897 (2020)

OBJECTIVES:miR-155 plays a critical role in the inflammatory process and in diseases such as rheumatoid arthritis (RA). miR155 gene expression is regulated by its gene promoter region CpG island methylation. Previous studies have shown inconsistent c

Externí odkaz: https://doaj.org/article/8ffd210451284999873d8b3ca11921f6

Comparison of clinical and serological parameters in female and male patients with systemic sclerosis

Autor: Ewa Wielosz, Maria Majdan, Magdalena Dryglewska, Dorota Suszek

Publikováno v: Rheumatology, Vol 53, Iss 6, Pp 315-320 (2016)

Objectives : The course of systemic sclerosis (SSc) can differ in female and male patients. According to the literature the incidence rates of diffuse cutaneous SSc, scleroderma renal crisis and digital ulceration are higher in male patients. The aim

Externí odkaz: https://doaj.org/article/fe45a6bf4b50414bafdcec29834be79b

Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosis

Autor: Magdalena Dryglewska, Ewa Wielosz, Maria Majdan

Publikováno v: Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii
Advances in Dermatology and Allergology, Vol 37, Iss 6, Pp 909-914 (2021)

Introduction Anti-RNA polymerase III (a-RNA Pol III) antibodies are marker antibodies in patients with systemic sclerosis (SSc). Aim To assess the prevalence of a-RNA Pol III in patients with SSc and to identify the differences in the disease picture

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b32f51eef7a22a5fb01bd4820ce502
http://europepmc.org/articles/PMC7874867

The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients

Autor: Maria Majdan, Marek Ciesla, Ann K. Rosenthal, Magdalena Dryglewska, Bogdan Kolarz

Publikováno v: Therapeutic Advances in Musculoskeletal Disease
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)

Background: Anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are key factors in the American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis (RA) classification criteria markers. However, about

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3e3a9be4f07be2a18ffc8ef6ab18ae
http://europepmc.org/articles/PMC7882754